Production & Sales

Aizon secures funds to accelerate development pipeline

Aizon, an artificial intelligence (AI) Software as a Service (SaaS) provider for pharmaceutical manufacturing operations, has secured $20m in Series C funding to expedite its development pipeline.

Kindeva Drug Delivery acquires Summit Biosciences

Kindeva Drug Delivery, a provider of drug-device combination products, has announced the acquisition of Summit Biosciences, an intranasal drug-delivery contract development and manufacturing organisation (CDMO).

Eurofins Alphora completes Canadian biologics development facility

Eurofins CDMO Alphora has announced the completion of a new pilot-scale biologics development facility in Canada.

AGC Biologics to build new facility in Japan

AGC Biologics has announced the establishment of a new manufacturing site at the AGC Yokohama Technical Center in Japan.

Lavipharm signs agreement with Sanofi to acquire Flagyl

Lavipharm has signed an agreement with Sanofi to acquire the pharmaceutical product, Flagyl, for the Greek market, for an undisclosed sum.

Otsuka Pharmaceutical submits NDA for voclosporin in Japan

Aurinia Pharmaceuticals’ collaboration partner Otsuka Pharmaceutical has submitted a new drug application (NDA) to the Japanese Ministry of Health, Labour and Welfare for voclosporin to treat lupus nephritis (LN).

Mithra signs license agreement with Searchlight for Donesta in Canada

Mithra Pharmaceuticals has entered into a license and supply agreement with Searchlight Pharma for the Canadian rights to Donesta.

Aldena chooses PCI to manufacture injectable dermatological treatment

Aldena Therapeutics has selected PCI Pharma Services (PCI) for manufacturing and distributing of ALD-102, an investigational treatment for dermatological diseases.

Y.S.P. Industries to market TaiGen’s new drug in Malaysia and Singapore

Y.S.P. Industries has entered into an exclusive licensing agreement to develop and market TaiGen Biopharmaceuticals Holdings’ (TaiGen) new drug in Malaysia and Singapore.